Cardiovascular & Hematological Disorders-Drug Targets
Title:Meet Our Associate Editor
Volume: 18 Issue: 1
Author(s): Jerzy Beltowski
Affiliation:
Export Options
About this article
Cite this article as:
Beltowski Jerzy , Meet Our Associate Editor, Cardiovascular & Hematological Disorders-Drug Targets 2018; 18 (1) . https://dx.doi.org/10.2174/1871529X1801180516171646
DOI https://dx.doi.org/10.2174/1871529X1801180516171646 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
Related Journals
Related Books
27
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inhibition of Tumor Cells Proliferation and Migration by the Flavonoid Furin Inhibitor Isolated From Oroxylum indicum
Current Medicinal Chemistry Sustained Release of Diltiazem Hydrochloride from Chitosan Microcapsules
Current Drug Delivery Sarcolemmal K<sub>ATP</sub> Channel Modulators and Cardiac Arrhythmias
Current Medicinal Chemistry Non-cirrhotic Portal Hypertension Associated with Didanosine and Streptococcus agalactiae Infection: A Case Report
Reviews on Recent Clinical Trials Leptin and Interleukin-1β Modulate Neuronal Glutamate Release and Protect Against Glucose-Oxygen-Serum Deprivation
Current Neurovascular Research Testosterone Deficiency Syndrome: Cellular and Molecular Mechanism of Action
Current Aging Science Determination of Torsade-Causing Potential of Drug Candidates Using One-Class Classification and Ensemble Modelling Approaches
Current Drug Safety Future of Protease Activity Assays
Current Pharmaceutical Design Review of the Pharmacology of the Emerging Possibilities of the Direct Oral Anticoagulants' Reversal
Current Drug Metabolism Urotensin II: A Vascular Mediator in Health and Disease
Current Vascular Pharmacology Dyslipidemia Management in 2020: An Update on Diagnosis and Therapeutic Perspectives
Endocrine, Metabolic & Immune Disorders - Drug Targets Meet Our Editorial Board Member
Current Cardiology Reviews Pro- and Anti-Arrhythmic Effects of Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases
Current Pharmaceutical Design Cardiorenal Consequences of Atherosclerosis and Statins Therapy: From the Past to the Future
Current Pharmaceutical Design Models for the Study of Angiogenesis
Current Pharmaceutical Design Strategies for Enhancing Progenitor Cell Mobilization and Function in Diabetes
Current Vascular Pharmacology Effects of Renin-Angiotensin-Aldosterone System Blockade on Diabetic Patients
Current Enzyme Inhibition Automatic Brain Aneurysm Extraction in Angiography Videos Using Circlet Transform and a Modified Level Set Model
Current Medical Imaging Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension
Current Vascular Pharmacology